As per industry analysts, India's pharmaceutical business might surpass USD 130 billion by 2030, owing to rising market potential and increased demand in international markets. They stated that the company's revenue for the fiscal year 2022-23 was...
Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company reinventing brain medication research, announced the start of a phase 1 single ascending dose/multiple ascending dosage trial in healthy adult volunteers to evaluate...
IRCAD India, a mirror institute of IRCAD France (Strasbourg), has recently been established in collaboration with the Sri Aurobindo Institute of Medical Sciences (SAIMS), Indore, India
Sami-Sabinsa Group Limited, a research-focused global health science company,has signed a mutual agreement with O2 Renewable Energy VIII Private Limited to establish a total installed capacity of 240 MW(100 MW of wind and 140 MW AC of solar) for...
Cadila Pharmaceuticals, located in Ahmedabad, has opened its state-of-the-art Active Pharmaceutical Ingredients (API) Plant in Dahej, Bharuch district. The Rs 200 crore facility is outfitted with the latest Distributed Control System (DCS)...
MC2 Therapeutics announced the enrollment of the first patients in a phase 2 proof-of-concept trial evaluating the safety and efficacy of MC2-25 VLS, an innovative new drug candidate for the treatment of urea-associated skin diseases, including...
Medicure Inc announced that the FDA has granted full approval to enroll patients in its pivotal phase 3 clinical trial to evaluate the use of its investigational product MC-1 for the treatment of pyridox(am)ine 5'-phosphate oxidase (PNPO)...
A new active pharmaceutical ingredient (API) factory was opened by the pharmaceutical business Rusan Pharma. With an annual production capacity of 400 metric tons of APIs, this plant is estimated to generate over 300 employment. The factory is...
Following the approval of bevacizumab for the treatment of metastatic colorectal cancer, Pune-based Enzene Biosciences has now launched ranibizumab, a biosimilar of the originator medication Lucentis, which is sold in India under the brand name...
DTx can be utilized independently or along with conventional treatments such as medication, face-to-face therapy, as well as various hardware, sensory, or mechanical devices.
, CDSCO.jpg)
